Latest News Archive
Please select Category, Year, and then Month to display items
![]()
#UFSupdate (18 March 2020): UFS IMPLEMENTS MEASURES TO MINIMISE RISK OF COVID-19 TO STAFF
STATEMENT BY PROF FRANCIS PETERSEN, RECTOR AND VICE-CHANCELLOR
The executive management of the University of the Free State (UFS) welcomes the announcement of Dr Blade Nzimande, Minister of Higher Education, Science and Technology on 17 March 2020 that all post-school training institutions will have an early recess, starting on 18 March 2020. The Minister’s directive that universities should minimise risk of COVID-19 to all its staff during this time is also welcomed.
The announcement of Dr Nzimande is in line with the university’s decision on 16 March 2020 to suspend the academic programme as from 17 March 2020 and to resume it again on 14 April 2020.
It is important for us all to know that this is not business as usual, and that different thinking is required. Responsible citizenship is one of the crucial elements the world has increasingly been experiencing for the past few weeks. This is why we must act out our responsibility towards one another by focusing on ways in which social distancing can be achieved – especially during this low-risk period that South Africa is still experiencing. This is one of the reasons that informed the university’s decision on 16 March 2020 week to suspend the academic programme and also for students to vacate the residences by 20 March 2020.
The health and well-being of our staff members are equally important. The university’s Employee Task Team that was established on 16 March 2020 analysed options for the continuation of university operations during the recess period. These options were submitted to the executive management, discussed with the Chairperson of the UFS Council and approved on 18 March 2020.
Staff members who have children at school and pre-school may work from home on 19 and 20 March 2020. For the period 23 March 2020 to 13 April 2020, the number of staff members present on all three campuses will be reduced to a minimum and staff members may be allowed to work from home where practically possible.
Arrangements have been made to accommodate those staff members who are performing services which cannot be done from home (such as cleaning, gardening, maintenance, sports, etc) in a flexible and reasonable way. Similar arrangements will be made with office-based support services staff, prioritising institutional needs and based on humane and personal circumstances. Academic staff have been requested to ensure that the online learning materials are finalised and made available for the online learning platform.
The decision for employees to work from home is based on the premise that all employees are deemed to be at work from 23 March 2020 to 13 April 2020. This requires staff members to be available and contactable by line managers at all times during the university’s normal working hours.
I am comfortable that these measures will alleviate the concerns from our staff regarding the spreading of COVID-19 and the risk to themselves without compromising university operations.
Prof F W Petersen
Rector and Vice-Chancellor
University of the Free State
UFS cardiac team leading with project
2017-05-31
Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin
A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.
An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.
“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.
International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.
“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.
“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.
“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”
Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”
Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.